IPDQF (Impedimed) Total Equity : $20.47 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Impedimed Total Equity?

Impedimed's total equity for the quarter that ended in Dec. 2024 was $20.47 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Impedimed Total Equity Historical Data

The historical data trend for Impedimed's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Total Equity Chart

Impedimed Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Equity

Get a 7-Day Free Trial

18.88

19.51

35.87

40.86

27.05

Impedimed Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Equity	Get a 7-Day Free Trial															27.48	40.86	34.13	27.05	20.47

Impedimed Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Impedimed's Total Equity for the fiscal year that ended in Jun. 2024 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2024 )	-	Total Liabilities(Q: Jun. 2024 )
	=	31.062	-	4.145
	=	26.92

Impedimed's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	24.819	-	4.353
	=	20.47

Impedimed Total Equity Related Terms

Thank you for viewing the detailed overview of Impedimed's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Impedimed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (OTCPK:IPDQF) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

IPD:Australia

Address

50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008

Website

https://www.impedimed.com

Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.